{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T09:46:03Z","timestamp":1786527963402,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/bf03401335","type":"journal-article","created":{"date-parts":[[2018,8,8]],"date-time":"2018-08-08T05:30:48Z","timestamp":1533706248000},"page":"213-221","source":"Crossref","is-referenced-by-count":34,"title":["Elevated serum androstenedione is associated with a more severe phenotype in women with polycystic ovary syndrome (PCOS)"],"prefix":"10.1007","volume":"13","author":[{"given":"Neoklis A.","family":"Georgopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstathios","family":"Papadakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia K.","family":"Armeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilias","family":"Katsikis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos D.","family":"Roupas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Panidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,1]]},"reference":[{"key":"BF03401335_CR1","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1210\/jc.2003-032046","volume":"98","author":"R Azziz","year":"2004","unstructured":"Azziz R, Woods KS, Reyna R, et al, 2004 The prevalence and features of the polycystic ovarian syndrome in an unselected population. J Clin Endocrinol Metab 98: 2745\u20132749.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03401335_CR2","first-page":"19","volume":"81","author":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group, 2004 Revised 2003 consensus on the diagnostic criteria and long term health risks related to polycystic ovary syndrome. Fertil Steril 81: 19\u201325.","journal-title":"Fertil Steril"},{"key":"BF03401335_CR3","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1210\/jc.2005-2153","volume":"91","author":"R Azziz","year":"2006","unstructured":"Azziz R, 2006 Controversy in clinical endocrinology: Diagnosis of polycystic ovarian syndrome: The Rotterdam criteria are premature. J Clin Endocrinol Metab 91: 781\u2013785.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03401335_CR4","doi-asserted-by":"publisher","first-page":"4842","DOI":"10.1210\/jc.2006-1327","volume":"91","author":"CK Welt","year":"2006","unstructured":"Welt CK, Gudmundsson JA, Arason G, et al, 2006 Characterizing different subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: The impact of weight on phenotype and metabolic features. J Clin Endocrinol Metab 91: 4842\u20134848.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03401335_CR5","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1210\/jc.2003-031122","volume":"89","author":"R Azziz","year":"2004","unstructured":"Azziz R, Sanchez LA, Knochenhauer ES, et al, 2004 Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab 89: 453\u2013462.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03401335_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1530\/EJE-10-0692","volume":"164","author":"R Pasquali","year":"2011","unstructured":"Pasquali R, Gambineri A, Cavazza C, et al, 2011 Heterogeneity in the responsiveness to long-term lifestyle intervention and predictability in obese women with polycystic ovary syndrome. Eur J Endocrinol 164: 53\u201360.","journal-title":"Eur J Endocrinol"},{"key":"BF03401335_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3121\/cmr.2008.796","volume":"6","author":"SA Doi","year":"2008","unstructured":"Doi SA, 2008 Neuroendocrine dysfunction in PCOS: a critique of recent reviews. Clin Med Res 6: 47\u201353.","journal-title":"Clin Med Res"},{"key":"BF03401335_CR8","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","volume":"21","author":"D Ferriman","year":"1961","unstructured":"Ferriman D, Gallwey JD, 1961 Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 21: 1440\u20131447.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03401335_CR9","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","volume":"84","author":"A Vermeulen","year":"1999","unstructured":"Vermeulen A, Verdonck L, Kaufman JM, 1999 A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84: 3666\u20133672.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03401335_CR10","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.fertnstert.2004.01.041","volume":"82","author":"E Carmina","year":"2004","unstructured":"Carmina E, Lobo RA, 2004 Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome. Fertil Steril 82: 661\u2013665.","journal-title":"Fertil Steril"},{"key":"BF03401335_CR11","first-page":"1158","volume":"79","author":"C Gilling-Smith","year":"1994","unstructured":"Gilling-Smith C, Willis DS, Beard RW, Franks S, 1994 Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. J Clin Endocrinol Metab 79: 1158\u20131165.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03401335_CR12","first-page":"3078","volume":"83","author":"ES Knochenhauer","year":"1998","unstructured":"Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R, 1998 Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 83: 3078\u20133082.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03401335_CR13","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","volume":"91","author":"R Azziz","year":"2009","unstructured":"Azziz R, Carmina E, Dewailly D, et al, 2009 Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS Society. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 91: 456\u2013488.","journal-title":"Fertil Steril"},{"key":"BF03401335_CR14","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1111\/j.1447-0756.2010.01478.x","volume":"37","author":"M Yilmaz","year":"2011","unstructured":"Yilmaz M, Isaoglu U, Delibas IB, Kadanali S, 2011 Anthropometric, clinical and laboratory comparison of four phenotypes of polycystic ovary syndrome based on Rotterdam criteria. J Obstet Gynaecol Res 37: 1020\u20131026.","journal-title":"J Obstet Gynaecol Res"},{"key":"BF03401335_CR15","first-page":"2317","volume":"83","author":"R Azziz","year":"1998","unstructured":"Azziz R, Black V, Hines GA, Fox LM, Boots LR, 1998 Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypotha-lamic-pituitary-adrenal axis. J Clin Endocrinol Metab 83: 2317\u20132323.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03401335_CR16","doi-asserted-by":"publisher","first-page":"4208","DOI":"10.1210\/jc.2007-0870","volume":"92","author":"R Pasquali","year":"2007","unstructured":"Pasquali R, Patton L, Pocognoli P, Cognigni GE, Gambineri A, 2007 17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome. J Clin Endocrinol Metab 92: 4208\u20134217.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03401335_CR17","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1677\/joe.1.06375","volume":"187","author":"MK Akhtar","year":"2005","unstructured":"Akhtar MK, Kelly SL, Kaderbhai MA, 2005 Cytochrome b(5) modulation of 17{alpha} hydroxylase and 17\u201320 lyase (CYP17) activities in steroidogenesis. J Endocrinol 187: 267\u2013274.","journal-title":"J Endocrinol"},{"key":"BF03401335_CR18","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1007\/BF03350785","volume":"21","author":"JE Hall","year":"1998","unstructured":"Hall JE, Taylor AE, Hayes FJ, Crowley WF Jr, 1998 Insights into hypothalamic pituitary dysfunction in polycystic ovary syndrome. J Endocrinol Invest 21: 602\u2013611.","journal-title":"J Endocrinol Invest"},{"key":"BF03401335_CR19","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1056\/NEJMra041536","volume":"352","author":"DA Ehrmann","year":"2005","unstructured":"Ehrmann DA, 2005 Polycystic ovary syndrome. N Engl J Med 352: 1223\u20131236.","journal-title":"N Engl J Med"},{"key":"BF03401335_CR20","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/S0188-4409(01)00325-3","volume":"32","author":"M Barontini","year":"2001","unstructured":"Barontini M, Garc\u00eda-Rudaz MC, Veldhuis JD, 2001 Mechanisms of hypothalamic-pituitary-gonadal disruption in polycystic ovarian syndrome. Arch Med Res 32: 544\u2013552.","journal-title":"Arch Med Res"},{"key":"BF03401335_CR21","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1093\/humrep\/16.10.2061","volume":"16","author":"S Greisen","year":"2001","unstructured":"Greisen S, Ledet T, Ovesen P, 2001 Effects of androstenedione, insulin and luteinizing hormone on steroidogenesis in human granulosa luteal cells. Hum Reprod 16: 2061\u20132065.","journal-title":"Hum Reprod"},{"key":"BF03401335_CR22","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.fertnstert.2008.10.064","volume":"93","author":"Y Okutsu","year":"2010","unstructured":"Okutsu Y, Itoh MT, Takahashi N, Ishizuka B, 2010 Exogenous androstenedione induces formation of follicular cysts and premature luteinization of granulosa cells in the ovary. Fertil Steril 93: 927\u2013935.","journal-title":"Fertil Steril"},{"key":"BF03401335_CR23","first-page":"2414","volume":"84","author":"AJ Jakimiuk","year":"1999","unstructured":"Jakimiuk AJ, Weitsman SR, Magoffin DA, 1999 5alpha-reductase activity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 84: 2414\u20132418.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03401335_CR24","first-page":"3686","volume":"81","author":"SK Agarwal","year":"1996","unstructured":"Agarwal SK, Judd HL, Magoffin DA, 1996 A mechanism for the suppression of estrogen production in polycystic ovary syndrome. J Clin Endocrinol Metab 81: 3686\u20133691.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03401335_CR25","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1210\/er.16.3.322","volume":"16","author":"DA Ehrmann","year":"1995","unstructured":"Ehrmann DA, Barnes BB, Rosenfield RL, 1995 Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 16: 322\u2013353.","journal-title":"Endocr Rev"},{"key":"BF03401335_CR26","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.fertnstert.2008.06.016","volume":"92","author":"DJ Marioli","year":"2009","unstructured":"Marioli DJ, Saltamavros AD, Vervita V, et al, 2009 Association of the 17-hydroxysteroid dehydrogenase type 5 gene polymorphism (-71A\/G HSD17B5 SNP) with hyperandrogenemia in polycystic ovary syndrome (PCOS). Fertil Steril 92: 648\u2013652.","journal-title":"Fertil Steril"},{"key":"BF03401335_CR27","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3109\/09513590.2011.613965","volume":"28","author":"G Misichronis","year":"2012","unstructured":"Misichronis G, Georgopoulos NA, Marioli DJ, et al, 2012 The influence of obesity on androstenedione to testosterone ratio in women with polycystic ovary syndrome (PCOS) and hyperandrogenemia. Gynecol Endocrinol 28: 249\u2013252.","journal-title":"Gynecol Endocrinol"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03401335\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03401335.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03401335.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,8,15]],"date-time":"2018-08-15T22:14:50Z","timestamp":1534371290000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03401335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["BF03401335"],"URL":"https:\/\/doi.org\/10.1007\/bf03401335","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}